A Novel Clinical Score Integrating Low‐Voltage Zones and Biomarkers Predicts Atrial Fibrillation Recurrence Post‐Ablation
This is the first East Asian study to integrate voltage mapping with hematological-inflammatory biomarkers, providing a cost-effective and precise tool for post-ablation management. The model's performance and generalizability support its adoption in precision medicine pathways, particularly for guiding substrate modification in high-risk patients.
Authors
- Jingzhe Liu
- Ying Han (ORCID: https://orcid.org/0000-0002-2424-5163)
- Juan Wang (ORCID: https://orcid.org/0000-0001-6027-1505)
- Juan Zhang (ORCID: https://orcid.org/0000-0001-6241-7176)
- Hanyue Zheng (ORCID: https://orcid.org/0009-0008-6942-3729)
- Xiaobo Liu (ORCID: https://orcid.org/0000-0002-8256-6002)
Institutions
- Second Hospital of Shandong University (CN)
- Shandong Mental Health Center (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Clinical Cardiology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/clc.70218
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province